Compare · MGRX vs VMD
MGRX vs VMD
Side-by-side comparison of Mangoceuticals Inc. (MGRX) and Viemed Healthcare Inc. (VMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MGRX and VMD operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- VMD is the larger of the two at $372.9M, about 52.7x MGRX ($7.1M).
- Over the past year, MGRX is down 75.8% and VMD is up 36.5% - VMD leads by 112.4 points.
- VMD has hit the wire 3 times in the past 4 weeks while MGRX has been quiet.
- VMD has more recent analyst coverage (1 ratings vs 0 for MGRX).
- Company
- Mangoceuticals Inc.
- Viemed Healthcare Inc.
- Price
- $0.43+8.01%
- $9.66+1.68%
- Market cap
- $7.1M
- $372.9M
- 1M return
- +34.71%
- +3.21%
- 1Y return
- -75.84%
- +36.54%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- News (4w)
- 0
- 3
- Recent ratings
- 0
- 1
Viemed Healthcare Inc.
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Latest MGRX
- SEC Form 10-K filed by Mangoceuticals Inc.
- SEC Form NT 10-K filed by Mangoceuticals Inc.
- SEC Form 4 filed by Cohen Jacob D.
- SEC Form 4 filed by Cohen Jacob D.
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
- Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
- Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Latest VMD
- SEC Form DEF 14A filed by Viemed Healthcare Inc.
- SEC Form DEFA14A filed by Viemed Healthcare Inc.
- Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
- SEC Form 4 filed by Moore Michael
- SEC Form 144 filed by Viemed Healthcare Inc.
- SEC Form 144 filed by Viemed Healthcare Inc.
- Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
- Viemed Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-K filed by Viemed Healthcare Inc.
- Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits